AJANTPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > ajantpharm

Technical Analysis

Technical Strength: 7.3 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 68.9. According to RSI analysis, ajantpharm is technically strong. 9.0 AJANTPHARM RSI Chart
MACD (?) MACD: 33.8 and Signal Line: 34.5. According to MACD analysis, ajantpharm is marginally weak. 3.0 AJANTPHARM MACD Chart
Simple Moving Average (?) 50-day simple moving average just got above it's 200-day simple moving average which is a positive signal. According to simple moving average analysis, ajantpharm is in a strong uptrend. Major support levels are 1500.378, 1414.887, 1413.365. 10.0 AJANTPHARM Simple Moving Average Chart
Exponential Moving Average (?) 50-day exponential moving average just got above it's 200-day exponential moving average which is a positive signal. According to exponential moving average analysis, ajantpharm is in a strong uptrend. Major support levels are 1497.321, 1427.785, 1426.7. 10.0 AJANTPHARM Exponential Moving Average Chart
Bollinger Bands (?) Bollinger bandwidth suggests a squeeze is happening, watch for a breakout above the upper band.%b is 1.1. According to bollinger bands, ajantpharm has hit the upper band which is a positive signal. 8.0 AJANTPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1414.964 and 1368.0. Resistance level is 1567.0. 6.5 AJANTPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 39.9 NA AJANTPHARM Average True Range Chart
Average Directional Index (?) ADX is 27.1 which means AJANTPHARM is in a trend. NA AJANTPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 19, 2018
Open Price 1533.25
High Price 1567.0
Low Price 1533.25
Close Price 1560.05
Absolute Change 26.85
Percentage Change 1.75%
Weekly Change 3.84%
Monthly Change 3.76%
Yearly Change -13.1%
52-week high 1852.95
52-week low 1120.05
Corporate Actions
ExDate Purpose
June 23, 2017 ANNUAL GENERAL MEETING
March 23, 2017 INT DIV RS 7/- PER SHARE
March 23, 2017 INTERIM DIVIDEND
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.713
Confidence in Beta2.04%
Market Capital Rs. 13727.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 43.76
TTM Price-to-Earnings (P/E) Ratio 35.7
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 January 2018: Deliverable Quantity:4.18e+04 NA AJANTPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 January 2018: Daily Volatility:0.3191 NA AJANTPHARM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 January 2018: PCR_OI:0.0802 PCR:0.1 NA AJANTPHARM PCR Chart
Option Pain (?) 19 January 2018: Max Pain:1500.0 NA AJANTPHARM Option Pain Chart
Premium (?) 19 January 2018 Premium: 5.6 Futures OI:1026000.0 NA AJANTPHARM Premium Chart
Option_MAX_OI (?) 19 January 2018: Price:1560.05 Put with maximum OI:1500.0 Call with maximum OI:1600.0 NA AJANTPHARM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 1565.65 1026000.0 963.0 1031.0 1560.05
February 22, 2018 1570.5 52500.0 79.0 83.0 1560.05

Announcements

January 16, 2018 Trading Window Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
December 15, 2017 Change in Director(s) Ajanta Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 16, 2018 January 25, 2018 Results To consider and approve inter-alia, Unaudited consolidated and standalone Financial Results of the Company for the third quarter ended December 31, 2017.
October 18, 2017 October 31, 2017 Results To consider and approve inter-alia, Unaudited consolidated and standalone Financial Results of the Company for the second quarter and half year ended September 30, 2017.
See all Board Meetings

AJANTPHARM is part of...

Index Weightage
NFTYMCAP50 NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1506 Rs. 1520 Rs. 1540 Rs. 1553 Rs. 1574 Rs. 1587 Rs. 1607